MaxCyte Inc (LON:MXCT)’s share price was up 5.1% during trading on Monday . The company traded as high as GBX 122 ($1.60) and last traded at GBX 123.50 ($1.62), approximately 2,878 shares were traded during mid-day trading. An increase of 48% from the average daily volume of 1,951 shares. The stock had previously closed at GBX 117.50 ($1.55).
The firm has a market cap of $71.74 million and a price-to-earnings ratio of -4.92. The company has a debt-to-equity ratio of 1.98, a current ratio of 2.64 and a quick ratio of 2.11. The firm has a fifty day simple moving average of GBX 116.90 and a two-hundred day simple moving average of GBX 125.75.
MaxCyte Company Profile (LON:MXCT)
MaxCyte, Inc operates as a cell-based medicines and life sciences company in the United States and internationally. Its transfection systems include MaxCyte STX, a scalable transfection system that uses flow electroporation technology for the engineering of cells for a range of applications; MaxCyte VLX, an instrument for large volume cell-engineering; and MaxCyte GT, a non-viral cell-engineering technology designed for clinical use.
Recommended Story: Stock Symbol
Receive News & Ratings for MaxCyte Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MaxCyte and related companies with MarketBeat.com's FREE daily email newsletter.